Kwmg LLC Has $16.51 Million Position in Cardinal Health, Inc. $CAH

Kwmg LLC cut its position in Cardinal Health, Inc. (NYSE:CAH) by 22.6% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 80,317 shares of the company’s stock after selling 23,495 shares during the quarter. Cardinal Health comprises about 1.4% of Kwmg LLC’s portfolio, making the stock its 21st biggest holding. Kwmg LLC’s holdings in Cardinal Health were worth $16,505,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Redhawk Wealth Advisors Inc. lifted its holdings in shares of Cardinal Health by 0.5% during the fourth quarter. Redhawk Wealth Advisors Inc. now owns 9,255 shares of the company’s stock worth $1,902,000 after buying an additional 48 shares in the last quarter. Latitude Advisors LLC increased its position in Cardinal Health by 2.1% during the third quarter. Latitude Advisors LLC now owns 2,598 shares of the company’s stock worth $408,000 after acquiring an additional 53 shares during the period. Barnes Dennig Private Wealth Management LLC increased its position in Cardinal Health by 38.7% during the fourth quarter. Barnes Dennig Private Wealth Management LLC now owns 190 shares of the company’s stock worth $39,000 after acquiring an additional 53 shares during the period. MFA Wealth Services raised its stake in Cardinal Health by 2.3% in the 3rd quarter. MFA Wealth Services now owns 2,491 shares of the company’s stock worth $391,000 after purchasing an additional 55 shares in the last quarter. Finally, Moody National Bank Trust Division raised its stake in Cardinal Health by 2.2% in the 4th quarter. Moody National Bank Trust Division now owns 2,696 shares of the company’s stock worth $554,000 after purchasing an additional 57 shares in the last quarter. Institutional investors own 87.17% of the company’s stock.

Cardinal Health Stock Up 0.4%

CAH stock opened at $212.11 on Thursday. The company’s 50-day moving average price is $217.37 and its two-hundred day moving average price is $197.66. The firm has a market cap of $49.91 billion, a P/E ratio of 30.52, a P/E/G ratio of 1.36 and a beta of 0.64. Cardinal Health, Inc. has a 12 month low of $120.72 and a 12 month high of $233.60.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings results on Thursday, February 5th. The company reported $2.63 earnings per share for the quarter, topping analysts’ consensus estimates of $2.31 by $0.32. The company had revenue of $65.63 billion during the quarter, compared to the consensus estimate of $64.88 billion. Cardinal Health had a net margin of 0.68% and a negative return on equity of 92.50%. The firm’s quarterly revenue was up 18.8% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.93 EPS. Equities analysts predict that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, April 15th. Shareholders of record on Wednesday, April 1st will be issued a $0.5107 dividend. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.0%. The ex-dividend date of this dividend is Wednesday, April 1st. Cardinal Health’s dividend payout ratio (DPR) is currently 29.35%.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on CAH. TD Cowen increased their target price on shares of Cardinal Health from $233.00 to $251.00 and gave the stock a “buy” rating in a research report on Wednesday, February 11th. Barclays lifted their price target on shares of Cardinal Health from $243.00 to $258.00 and gave the company an “overweight” rating in a research report on Tuesday, February 24th. JPMorgan Chase & Co. boosted their price target on Cardinal Health from $209.00 to $243.00 and gave the company a “neutral” rating in a research note on Tuesday, February 10th. Robert W. Baird set a $252.00 price objective on Cardinal Health in a research note on Friday, February 6th. Finally, Jefferies Financial Group lifted their price objective on Cardinal Health from $220.00 to $270.00 and gave the company a “buy” rating in a report on Thursday, January 22nd. One investment analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat, Cardinal Health has an average rating of “Moderate Buy” and an average price target of $245.67.

Cardinal Health Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.